AET - Aetna Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
0.0000
0.0000 (0.33%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close0.0000
Open212.5700
Bid0.00 x 1100
Ask0.00 x 900
Day's Range211.7900 - 213.3600
52 Week Range211.7900 - 213.3600
Volume11,862,705
Avg. VolumeN/A
Market CapN/A
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Apple should buy private digital health records operation...
    CNBC Videoslast month

    Apple should buy private digital health records operation...

    Jim Cramer says the move would boost Apple's stock price and give the company a surefire way to solidify its place in the health-care arena.

  • JPMorgan health-care expert: Mergers, drug pricing and 20...
    CNBC Videos2 months ago

    JPMorgan health-care expert: Mergers, drug pricing and 20...

    Jim Cramer gets a preview of J.P. Morgan's upcoming health-care conference with the firm's top health-care analyst, Lisa Gill.

  • Investing.com3 days ago

    CVS Tumbles After Fresh $2.2 Billion Hit to Long-Term Care Business

    Investing.com - Shares in CVS (NYSE:CVS) tumbled Wednesday after the company was forced to take another $2.2 billion charge against its struggling long-term care business, built around its 2015 acquisition of Omnicare.

  • Reuters25 days ago

    Apple Watch, using Aetna client data, wants to help you be healthy

    Called "Attain," the Apple Watch app will reward Aetna customers for meeting activity goals and fulfilling recommended tasks, such as getting vaccinations or refilling medications, with a subsidy towards the cost of an Apple Watch or gift cards for U.S. retailers. Several insurers have offered such subsidies for using wearable devices to meet generic activity goals such as a number of steps in the past.

  • Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
    Reuters28 days ago

    Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen

    CVS Health Corp, a top U.S. manager of pharmacy benefits, has added new migraine drugs from Teva Pharmaceutical Industries and Eli Lilly and Co to its list of covered drugs, excluding a rival treatment from Amgen Inc, a CVS spokeswoman told Reuters on Friday. CVS's decision represents a setback for sales of Amgen's Aimovig, as many patients who rely on the coverage list will now have easier access to the rival Teva and Lilly drugs. Inclusion on the preferred drugs lists by the largest pharmacy benefit managers (PBMs) and health insurers is seen as critically important for sales of new medicines.

  • Reuters29 days ago

    Aetna, other health insurers team up with IBM on blockchain project

    The companies intend to use blockchain technology, which allows the sharing of databases across a network of computers, for processing claims and payments and to maintain directories, they said in a joint statement. Blockchain, the technology that underpins crypto-currencies such as bitcoin, is being increasingly adopted across varied industries. Financial services firms too note the distributed ledger technology has the potential to generate wide-ranging savings.

  • Reuterslast month

    CVS unveils 'Beauty Marks' in stores, warning shoppers of edited images

    CVS Pharmacy unveiled an initiative in U.S. stores on Thursday, labeling photos of models in its beauty aisles to make it clear whether the images had been digitally altered. The U.S. No 2 drugstore chain, part of CVS Health Corp , is the first major American company to adopt such a policy in the face of rising concerns about doctored images setting unrealistic ideals of beauty, especially for young women. The retailer said on Thursday that 70 percent of all in-store beauty imagery was now flagged as "beauty unaltered" or "digitally altered." The company announced its "Beauty Mark" initiative a year ago, but only on Thursday did it appear in stores.

  • The Wall Street Journallast month

    Walmart Could Leave CVS Caremark Pharmacy Networks Amid Dispute

    CVS Health Corp. is battling Walmart Inc. over the cost of filling prescriptions, a clash that could result in a split between the retail behemoth and the health-care giant. Walmart is expected to leave CVS Caremark pharmacy networks over the dispute, a split that could occur as soon as early February, though CVS said it has asked for an extension through April 30. CVS Caremark, the pharmacy-benefits unit of CVS Health, said Monday that Walmart is seeking an increase in what the retailer gets paid for prescriptions, which would “ultimately result in higher costs for our clients and consumers.” CVS Caremark, which is separate from CVS’s retail drugstores, reimburses pharmacies when shoppers with CVS Caremark prescription coverage buy medicine.

  • Benzingalast month

    Raymond James: CVS A Strong Buy Despite Pricing Headwinds

    Raymond James is making more conservative assumptions and lowered its 2019 earnings per share estimate by 30 cents to $7.40. The Raymond James note was issued before CVS announced later Tuesday that Walmart would no longer participate in the network of providers where customers of some of CVS’s Caremark pharmacy benefit programs can have their prescriptions filled.

  • Walmart opts to leave CVS partnerships over pricing dispute
    Reuterslast month

    Walmart opts to leave CVS partnerships over pricing dispute

    CVS said the dispute would not impact Walmart's presence in its Medicare Part D pharmacy network, which according to Cowen & Co analyst Charles Rhyee was a bright spot as it represented a larger chunk of CVS' scripts. "At a time when everyone is working hard to find ways to reduce healthcare costs, Walmart's requested rates would ultimately result in higher costs for our clients and consumers," Derica Rice, president of CVS Caremark, said in a statement https://cvshealth.com/newsroom/press-releases/cvs-health-announces-walmart-decision-leave-cvs-caremark-commercial-and. Walmart spokeswoman Marilee McInnis said the retailer was continuing discussions with CVS Caremark, the company's pharmacy benefits unit.

  • CNBClast month

    Walmart pharmacies likely to leave CVS network because of pricing dispute

    CVS announced Tuesday that Walmart pharmacies are leaving its network because of a dispute over pricing. Both Walmart and CVS are saying that the other company is trying to make prescriptions more expensive for consumers. Walmart WMT pharmacies are expected to leave the drugstore networks offered by CVS CVS because of an ongoing pricing dispute.

  • CNBClast month

    CVS pledges $100 million for community health programs

    CVS will spend $100 million to support community health programs over five years. The initiative comes in the wake of CVS' roughly $70 billion acquisition of health insurer Aetna. CVS has positioned its acquisition of Aetna around its commitment to finding ways to lower health-care costs.

  • GuruFocus.comlast month

    Cvs Health Corp (CVS) President and CEO Larry J Merlo Sold $11.5 million of Shares

    President and CEO of Cvs Health Corp (NYSE:CVS) Larry J Merlo sold 166,368 shares of CVS on 01/08/2019 at an average price of $69.04 a share.

  • Why CVS Health Shares Dropped 18% in December
    Motley Foollast month

    Why CVS Health Shares Dropped 18% in December

    Closing the Aetna acquisition in November gave the pharmacy chain much more muscle. But investors are justifiably cautious about how the marriage will play out.

  • The Wall Street Journallast month

    [$$] Health-Care CEOs Outline Strategies at J.P. Morgan Conference

    One of the biggest health conferences of the year for investors, the J.P. Morgan Health-Care Conference, is taking place this week in San Francisco. BioMarin Pharmaceutical Inc. CEO Jean-Jacques Bienaimé said he would consider pursuing installment payment arrangements for the biotech’s experimental gene therapy for hemophilia. At the conference, Mr. Bienaimé told the Wall Street Journal that the one-time infusion, Valrox, is likely to cost in the millions because studies have shown it can eliminate bleeding episodes in patients, and current hemophilia treatments taken chronically can cost millions over several years.

  • GuruFocus.comlast month

    Bill Nygren Comments on CVS Health

    Guru stock highlight

  • CEO departures hit highest level since recession
    Yahoo Financelast month

    CEO departures hit highest level since recession

    A record number of CEOs left their posts in 2018.

  • U.S. government says shutdown may slow resolution of CVS/Aetna court process
    Reuterslast month

    U.S. government says shutdown may slow resolution of CVS/Aetna court process

    The Justice Department has said in a court filing that a partial government shutdown could delay its response to comments on pharmacy chain CVS Health Corp's purchase of health insurer Aetna, a necessary step in a court giving final approval to the deal. Judge Richard Leon of the U.S. District Court for the District of Columbia has been reviewing a consent decree reached by the government and the companies in October to allow their $69 billion merger.

  • 3 Reasons Why CVS Health Thinks Its $78 Billion Bet Can Make You a Lot of Money
    Motley Foollast month

    3 Reasons Why CVS Health Thinks Its $78 Billion Bet Can Make You a Lot of Money

    CVS Health spent a fortune to buy Aetna. CEO Larry Merlo explained at the J.P. Morgan Healthcare Conference why it should pay off for investors.

  • Motley Fool2 months ago

    Year In Review Part II: Stories That Got Away

    Ringing in the new year, we look back at how 2018 treated energy, financials, healthcare, and tech.

  • CVS Got Aetna. Next Up, Reimagining Health Care.
    Bloomberg2 months ago

    CVS Got Aetna. Next Up, Reimagining Health Care.

    Now, after guiding CVS through its $69 billion acquisition of insurer Aetna Inc., he has the chance to cap off his career by successfully managing this expensive experiment and, in the process, creating a template for the future of American health care. The merger creates a company that’s singular in its size and scope, combining CVS’s nearly 10,000 stores and 1,100 clinics with Aetna’s 22 million enrollees. It also includes CVS Caremark, a leader among pharmacy benefit managers. Merlo — a pharmacist by training who’s been CEO since 2011 — has said the idea is to create a more local, coordinated, and accessible “front door” to health care. “We look at the industry and we define it as one that's fragmented, and often times care is uncoordinated,” he said at a recent Evercore ISI health-care conference.

  • GuruFocus.com2 months ago

    5 Companies Hit 52-Week Highs

    As of late, multiple companies have managed to achieve yearly highs

  • 5 Great Healthcare Stocks to Buy for 2019
    Zacks2 months ago

    5 Great Healthcare Stocks to Buy for 2019

    Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.